However, atherosclerosis and hypertension impair NO bioavailability due to lower eNOS expression, eNOS inactivation, changes in Cav-1 expression or NOX4 activity, and eNOS uncoupling, leading to deleterious ROS overproduction. The gene discussed is CAV1; the disease is atherosclerosis.